Investors who lost money on Nutex Health Inc.(NUTX) should contact Levi & Korsinsky about pending Class Action - NUTX
- NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 10/09/2025
|
Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NUTX
- NEW YORK , Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 10/09/2025
|
NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Oct. 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline. So what: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 10/08/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- SAN FRANCISCO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 10/08/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Oct. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 10/08/2025
|
NUTX DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 10/08/2025
|
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE BEFORE OCTOBER 21, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 10/07/2025
|
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX
- LOS ANGELES , Oct. 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex " or "the Company") (NASDAQ: NUTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
- 10/07/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Oct. 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 8, 2024 and August 14, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before October 21, 2025.
- 10/07/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 10/06/2025
|
NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Investors to Contact the Firm Before the October 21st Deadline
- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
- 10/06/2025
|
NUTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 10/06/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Nutex Health Inc. Investors of Upcoming Deadline
- NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?
- 10/06/2025
|
Nutex Health Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights - NUTX
- NEW YORK , Oct. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 10/06/2025
|
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
- HOUSTON , Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced 20 awards and honors the Company and its hospitals received in the third quarter of 2025, the most in company history. Nutex Health hospitals have historically served as the go-to medical facilities for the communities in which we serve.
- 10/06/2025
|
NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 10/05/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 10/05/2025
|
NUTX INVESTORS: Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Important Deadline in Class Action Lawsuit
- NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
- 10/03/2025
|
NUTX Deadline: NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline. So what: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 10/03/2025
|
NUTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 10/03/2025
|
Deadline Alert: Nutex Health Inc. (NUTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 10/03/2025
|
NUTEX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Nutex Investors of the October 21st Deadline and Urges Investors to Contact the Firm Regarding the Filed Class Action Lawsuit
- Nutex allegedly relied on fraudulent HaloMD arbitration revenues, overstated remediation of controls, and misclassified stock comp, overstating prospects.
- 10/03/2025
|
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 10/03/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 10/03/2025
|
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Oct. 2, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) have opportunity to lead the securities fraud class action lawsuit.
- 10/02/2025
|
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX
- LOS ANGELES , Oct. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex " or "the Company") (NASDAQ: NUTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
- 10/02/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Oct. 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 8, 2024 and August 14, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before October 21, 2025.
- 10/02/2025
|
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NUTX
- LOS ANGELES , Oct. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex " or "the Company") (NASDAQ: NUTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
- 10/02/2025
|
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Nutex Health Inc. (NASDAQ: NUTX)
- NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8 , 202 4 and August 14 , 202 5, inclusive. Should You Join This Class Action Lawsuit?
- 10/02/2025
|
Nutex Health Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – NUTX
- NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 10/01/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman
- SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 10/01/2025
|
Lost Money on Nutex Health Inc.(NUTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
- NEW YORK , Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025.
- 10/01/2025
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/30/2025
|
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , Sept. 30, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 09/30/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 09/30/2025
|
NUTEX LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Nutex Investors to Contact the Firm Regarding the Filed Class Action Lawsuit
- Nutex allegedly used HaloMD in a fraud scheme boosting arbitration revenues, misstated controls and stock comp, overstated prospects, and misled investors.
- 09/29/2025
|
The Gross Law Firm Notifies Nutex Health Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – NUTX
- NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/29/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- SAN FRANCISCO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/29/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
- 09/29/2025
|
Nutex Health Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit
- SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Nutex Health Inc. (NASDAQ: NUTX) (“Nutex” or the “Company”). The lawsuit seeks to recover losses on behalf of investors who purchased the Company's securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 09/29/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Nutex Health Inc. Investors of Upcoming Deadline
- NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Nutex Health Inc. (NASDAQ: NUTX)?
- 09/29/2025
|
Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact The Gross Law Firm
- NEW YORK , Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/29/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 09/28/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/28/2025
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/27/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 09/26/2025
|
Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/26/2025
|
Class Action Filed Against Nutex Health Inc. (NUTX) - October 21, 2025 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/25/2025
|
Faruqi & Faruqi Reminds Nutex Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 - NUTX
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 09/25/2025
|
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX
- LOS ANGELES--(BUSINESS WIRE)--Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX.
- 09/25/2025
|
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
- NEW YORK , Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/25/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Nutex Health Inc. Investors of Upcoming Deadline
- NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
- 09/25/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 09/24/2025
|
NUTEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Nutex Health Inc. and Encourages Investors to Contact the Firm
- The Nutex lawsuit alleges it overstated controls, misclassified stock comp, and relied on allegedly fraudulent HaloMD revenues, overstating prospects.
- 09/24/2025
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/24/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers – NUTX
- NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 09/24/2025
|
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.
- 09/24/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Sept. 23, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
- 09/23/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
- 09/23/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/23/2025
|
Nutex Health Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – NUTX
- NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/22/2025
|
Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
- NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Nutex investments, you have until October 21, 2025 to request lead plaintiff appointment. Follow the l.
- 09/22/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme – Hagens Berman
- SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 09/22/2025
|
Lowey Dannenberg Notifies Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
- NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) for violations of the federal securities laws on behalf of investors who purchased or acquired Nutex securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 09/22/2025
|
Investors who lost money on Nutex Health Inc. (NUTX) should contact The Gross Law Firm about pending Class Action - NUTX
- NEW YORK , Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/22/2025
|
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
- HOUSTON , Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Wesley Bamburg as the Company's Chief Operating Officer, effective October 13, 2025.
- 09/22/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
- 09/22/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 09/21/2025
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/21/2025
|
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options
- 09/21/2025
|
Investors in Nutex Health Inc. Should Contact Levi & Korsinsky Before October 21, 2025 to Discuss Your Rights – NUTX
- NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/19/2025
|
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 09/19/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- NUTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Sept. 19, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/19/2025
|
Faruqi & Faruqi Reminds Nutex Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 - NUTX
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.
- 09/18/2025
|
Shareholders that lost money on Nutex Health Inc. (NUTX) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
- NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/18/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Sept. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R.
- 09/18/2025
|
ROSEN, A LEADING GLOBAL LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/18/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/18/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Nutex Health Inc. Investors of Upcoming Deadline
- NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
- 09/18/2025
|
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in Nutex Health Inc. Lawsuit - NUTX
- NEW YORK , Sept. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/18/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Sept. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
- 09/18/2025
|
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 09/17/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Sept. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
- 09/17/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/17/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO , Sept. 16, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/16/2025
|
Investors who lost money on Nutex Health Inc. (NUTX) should contact Levi & Korsinsky about pending Class Action - NUTX
- NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/16/2025
|
Levi & Korsinsky Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/16/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Sept. 15, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
- 09/15/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 09/14/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.
- 09/13/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/13/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman
- SAN FRANCISCO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 09/12/2025
|
Levi & Korsinsky Notifies Nutex Health Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NUTX
- NEW YORK , Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/12/2025
|
Faruqi & Faruqi Reminds Nutex Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 - NUTX
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 09/11/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- NUTX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Sept. 11, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/11/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in Nutex Health Inc. Lawsuit – NUTX
- NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/11/2025
|
Nutex Health Inc. Investors: Company Investigated by the Portnoy Law Firm
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 09/11/2025
|
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
- NEW YORK , Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/11/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Sept. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
- 09/10/2025
|
Nutex Health Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – NUTX
- NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/10/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/10/2025
|
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 09/10/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers – NUTX
- NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 09/10/2025
|
Did You Lose Money in Nutex Health Inc.? If you Lost Money in Nutex Health Inc., Contact Robbins LLP for Information About the NUTX Securities Class Action Lawsuit
- SAN DIEGO , Sept. 9, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025.
- 09/09/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Sept. 9, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
- 09/09/2025
|
Levi & Korsinsky Notifies Nutex Health Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – NUTX
- NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/08/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/08/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Sept. 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
- 09/08/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/08/2025
|
Nutex Health Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights - NUTX
- NEW YORK , Sept. 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
- 09/08/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.
- 09/06/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers – NUTX
- NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 09/06/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
- NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
- 09/05/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
- 09/05/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.
- 09/05/2025
|
Lowey Dannenberg Notifies Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
- NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) for violations of the federal securities laws on behalf of investors who purchased or acquired Nutex securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 09/05/2025
|
Class Action Filed Against Nutex Health Inc. (NUTX) - October 21, 2025 Deadline to Join - Contact Levi & Korsinsky
- NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
- 09/05/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- NUTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Sept. 4, 2025 /PRNewswire/ -- A new class-action lawsuit alleges that Nutex Health, Inc. (NASDAQ: NUTX), a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in losses for investors.
- 09/04/2025
|
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
- SAN FRANCISCO , Sept. 4, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results.
- 09/04/2025
|
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options
- 09/03/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , Sept. 3, 2025 /PRNewswire/ -- The Law Offices of Frank R.
- 09/03/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers.
- 09/03/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES , Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
- 09/03/2025
|
Robbins LLP Reminds NUTX Investors with Large Losses of the Pending Class Action Against Nutex Health Inc. and Urges Stockholders to Contact the Firm for More Information
- SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025.
- 09/02/2025
|
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2025.
- 09/02/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers – NUTX
- NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 09/02/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Nutex Health Inc. Investors of Upcoming Deadline
- NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
- 09/02/2025
|
Shareholders who lost money in shares of Nutex Health Inc. (NASDAQ: NUTX) Should Contact Wolf Haldenstein Immediately
- Lead Plaintiff Deadline is October 21, 2025 NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is informing investors about a class action lawsuit against Nutex Health Inc. (NASDAQ: NUTX) (“Nutex”).
- 09/02/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit alleges that Nutex Health, Inc. (NASDAQ: NUTX), a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in losses for investors. The complaint follows a scathing short-seller report that triggered a sharp decline in the company's stock price and raised questions about its financial disclosures.
- 09/02/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Aug. 31, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 08/31/2025
|
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”).
- 08/29/2025
|
Shareholders who lost money in shares of Nutex Health Inc. (NASDAQ: NUTX) Should Contact Wolf Haldenstein Immediately
- NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is informing investors about a class action lawsuit against Nutex Health Inc. (NASDAQ: NUTX) (“Nutex”). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Case Summary: Nutex Health Inc. Securities Class Action Class Period: August 8, 2024 – August 14, 2025 Deadline to File Lead Plaintiff Motion: October 21, 2025 Court: United States District Court for the Southern District of Texas Allegations The lawsuit alleges that Nutex and its executives made false and misleading statements and failed to disclose material facts about its business and finances.
- 08/28/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period").
- 08/27/2025
|
Deadline Approaching: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOI.
- 08/27/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 08/27/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
- NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv- 03999, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 08/27/2025
|
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2025.
- 08/26/2025
|
NUTEX HEALTH INC. (NASDAQ: NUTX) INVESTOR ALERT: Investors With Large Losses in Nutex Health Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
- NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, inclusive. For more information, submit a form at Nutex Health Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030.
- 08/26/2025
|
Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action
- LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action.
- 08/26/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
- SAN FRANCISCO , Aug. 26, 2025 /PRNewswire/ -- A new class-action lawsuit alleges that Nutex Health, Inc. (NASDAQ: NUTX), a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in losses for investors. The complaint follows a scathing short-seller report that triggered a sharp decline in the company's stock price and raised questions about its financial disclosures.
- 08/26/2025
|
Nutex Health Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Nutex Health Inc.
- SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025. Nutex is a physician-led, healthcare services and operations company that began publicly trading via a reverse merger in April 2022.
- 08/25/2025
|
Nutex Health Inc. (NUTX) Q2 2025 Earnings Call Transcript
- Nutex Health Inc. (NASDAQ:NUTX ) Q2 2025 Earnings Conference Call August 25, 2025 10:30 AM ET Company Participants Jon C. Bates - Chief Financial Officer Michael Chang - Chief Medical Officer Thomas T.
- 08/25/2025
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Nutex Health Inc. (NUTX) Investors to Inquire About Securities Fraud Class Action
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR NUTE.
- 08/25/2025
|
NUTEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Nutex Health Inc. and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options
- 08/25/2025
|
[NUTX] ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Nutex Health Inc. Investors
- NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities during the period of August 8, 2024 through August 14, 2025, inclusive (“the Class Period”).
- 08/25/2025
|
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) and certain of its officers.
- 08/25/2025
|
Law Offices of Howard G. Smith Encourages Nutex Health Inc. (NUTX) Investors To Inquire About Securities Fraud Class Action
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). Nutex investors have until October 21, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PART.
- 08/25/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Lawsuit
- NEW YORK , Aug. 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 08/25/2025
|
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
- NEW YORK--(BUSINESS WIRE)---- $NUTX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm h.
- 08/25/2025
|
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)---- $NUTX--NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm.
- 08/25/2025
|
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman
- SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit alleges that Nutex, a hospital and healthcare services company, engaged in a fraudulent scheme with a third-party billing firm to inflate its revenues, leading to millions of dollars in losses for investors. The complaint follows a scathing short-seller report that triggered a sharp decline in the company's stock price and raised questions about its financial disclosures.
- 08/25/2025
|
Rosen Law Firm Urges Nutex Health Inc. (NASDAQ: NUTX) Stockholders to Contact the Firm for Information About Their Rights
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025. Nutex describes itself as a “physician-led, healthcare services and operations company.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations.
- 08/25/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- 08/21/2025
|
NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
- HOUSTON , Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today disclosed non-reliance on its (i) unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 contained in the Form 10-Q for the period ended March 31, 2025 (the "Original Form 10-Q") and its (ii) audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 contained in the Form 10-K for the year ended December 31, 2024 and 2023 (the "Original Form 10-K") (collectively, the "Previously Issued Financial Statements"). As noted in the 8-K filed today, on August 20, 2025, the Company, in consultation with the Audit Committee of the Board of Directors and its Auditor, reached a determination that the Company's Previously Issued Financial Statements should no longer be relied upon solely due to changes to the non-cash classification of obligations related to under construction and ramping hospitals from equity to liability in accordance with the classification criteria in ASC 718, Compensation - Stock Compensation, and ASC 480, Distinguishing Liabilities from Equity.
- 08/20/2025
|
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report – Hagens Berman
- SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 – a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.
- 08/20/2025
|
Kirby McInerney LLP Announces Investigation Against Nutex Health Inc. on Behalf of Investors
- NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). The investigation concerns whether Nutex and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
- 08/20/2025
|
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On July 22, 2025, Blue Orca Capital publ.
- 08/19/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email.
- 08/18/2025
|
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.
- 08/18/2025
|
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 22, 2025, Blue Orca Capital published a report alleging, among.
- 08/18/2025
|
Johnson Fistel Investigates Nutex Health Following Short Report and Delayed SEC Filing
- SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Nutex Health Inc. (NASDAQ: NUTX) regarding possible violations of federal securities laws. Investors who purchased Nutex Health securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.
- 08/18/2025
|
INVESTOR ALERT: Investigation of Nutex Health Inc. (NUTX) Announced by Holzer & Holzer, LLC
- ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) complied with federal securities laws. On July 22, 2025, Blue Orca Capital released a report regarding, among other things, Nutex's reimbursement rates. Following this news, the price of the Company's stock dropped.
- 08/18/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- 08/17/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/16/2025
|
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.
- 08/15/2025
|
NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)---- $NUTX--NUTX Investors Have Opportunity to Join Nutex Health Inc. Fraud Investigation with the Schall Law Firm.
- 08/15/2025
|
NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
- HOUSTON , Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will delay filing its Form 10-Q for the period ending June 30, 2025 due to non-cash accounting adjustments related to the treatment of stock based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings. The Company additionally provided preliminary financial results for the three and six months ended June 30, 2025 and announced a stock repurchase program of up to $25.0 million.
- 08/14/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- 08/13/2025
|
NUTEX (NUTX) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options
- 08/12/2025
|
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report – Hagens Berman
- SAN FRANCISCO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.
- 08/12/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/11/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- 08/09/2025
|
Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call
- HOUSTON , Aug. 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2025 after the close of the stock market on Thursday, August 14, 2025. The Company will discuss those results on a conference call on Friday, August 15, 2025, at 10:30 a.m.
- 08/08/2025
|
NUTEX (NUTX) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options
- 08/06/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/06/2025
|
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.
- 08/05/2025
|
NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options
- 08/04/2025
|
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD. Blue Orca's accusations have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Nutex may have misled investors about the propriety of steps taken in response to recent federal protections for consumers and urges Nutex investors who suffered substantial losses to submit your losses now.
- 07/31/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK , July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 07/31/2025
|
NUTEX HEALTH TO RING NASDAQ BELL AND MEET WITH INVESTORS IN NYC ON AUGUST 26
- HOUSTON , July 29, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced that its Directors and Officers will be ringing the closing Nasdaq bell in New York City on Tuesday, August 26 and hosting an investor meet and greet that morning in Midtown Manhattan. Investor Meet and Greet: Date: August 26, 2025 Time: 9 am EST to 1 pm EST Location: Disclosed upon scheduling The Nutex Health team is happy to meet with investors who are interested in connecting in-person.
- 07/29/2025
|
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO , July 28, 2025 /PRNewswire/ -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution ("IDR") vendor HaloMD. Blue Orca's accusations have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Nutex may have misled investors about the propriety of steps taken in response to recent federal protections for consumers and urges Nutex investors who suffered substantial losses to submit your losses now.
- 07/28/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
- NEW YORK , July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 07/27/2025
|
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman
- SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.
- 07/25/2025
|
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Nutex Health Inc. (NASDAQ: NUTX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
- HOUSTON , July 25, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Nutex Health Inc. ("Nutex") (NASDAQ: NUTX), resulting from allegations of providing potentially misleading business information to the investing public. If you are a Nutex investor who suffered a substantial loss and would like to learn more, you can provide your information HERE.
- 07/25/2025
|
Nutex Health Inc. Investors: Company Investigated by the Portnoy Law Firm
- Investors can contact the law firm at no cost to learn more about recovering their losses
- 07/25/2025
|
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On July 22, 2.
- 07/25/2025
|
Nutex Health Inc. (NUTX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NUTEX HEALTH INC. (NUTX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email a.
- 07/24/2025
|
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 22, 2025, Blue Orca Capital published a report alleging, among.
- 07/24/2025
|
Nutex Health Responds to Short Seller Report
- HOUSTON , July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today provided the following response to a misleading short attack. The Company is aware of the allegations made in a recent short seller report that attempts to call into question the Company's collection process.
- 07/23/2025
|
INVESTOR ALERT: Investigation of Nutex Health Inc. (NUTX) Announced by Holzer & Holzer, LLC
- ATLANTA, July 23, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) complied with federal securities laws. On July 22, 2025, Blue Orca Capital released a report regarding, among other things, Nutex's reimbursement rates. Following this news, the price of the Company's stock dropped.
- 07/23/2025
|
Johnson Fistel Investigates Nutex Health Following Short Report
- SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Nutex Health Inc. (NASDAQ: NUTX) regarding possible violations of federal securities laws. Investors who purchased Nutex Health securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.
- 07/23/2025
|
Nutex Health: At An Inflection Point
- Nutex Health's financial turnaround is driven by IDR wins, robust revenue growth, and a superior urban microhospital model with industry-leading profitability. Shares are deeply undervalued at 2.1x EV/EBITDA and >30% FCF yield, with significant upside as the market underappreciates Nutex's earnings power and cash flow. Management's heavy insider ownership and consistent share purchases signal long-term commitment and confidence in the business model's sustainability.
- 07/16/2025
|
NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS
- HOUSTON , July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced various community-driven accolades the Company and its hospitals received in the second quarter of 2025. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.
- 07/08/2025
|
Nutex Health: Justified Dilution Given Explosive Growth In Free Cash Flow
- Nutex Health delivered a blowout Q1 2025, with $51M in free cash flow and 214% y/y revenue growth, driven by arbitration wins. A frank discussion of its equity dilution. The company's growth is impressive but erratic, with limited visibility and heavy reliance on non-recurring arbitration revenue.
- 06/30/2025
|
NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT
- HOUSTON , June 27, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced that it has filed a supplement to the proxy statement it filed on June 2, 2025. The Company encourages shareholders to review the supplement filed today.
- 06/27/2025
|
NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
- HOUSTON , June 24, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced it has been added as a member of the broad-market Russell 3000® Index and the Russell Microcap® Index, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization.
- 06/24/2025
|
Nutex Health Leverages Arbitration To Unlock Hidden Value
- Nutex Health is a speculative buy, exploiting a unique arbitrage model under the No Surprises Act for strong revenue and profit growth. The micro-hospital strategy, physician ownership, and focus on efficiency drive staff stability and operational expansion, supporting sustainable volume growth. Financials are robust: Q1 saw a 213% sales jump, a 56% gross margin, strong cash flow, and a healthy balance sheet with modest debt.
- 06/19/2025
|
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
- HOUSTON , June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2025 annual meeting to be held on July 14, 2025 at 10:00 am Central Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2025 . We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote.
- 06/02/2025
|
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong Momentum
- NUTX is transforming from a turnaround story to a high-growth, high-risk play, driven by explosive revenue and profitability from its micro-hospital model. The company's financials show triple-digit revenue growth, margin expansion, and strong operating leverage, with positive analyst sentiment and technical momentum. Key risks include heavy reliance on arbitration revenue, significant lease liabilities, and regulatory uncertainty, making this a volatile but compelling opportunity.
- 05/29/2025
|
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
- HOUSTON , May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company.
- 05/22/2025
|
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
- Nutex Health Inc. (NASDAQ:NUTX ) Q1 2025 Earnings Conference Call May 14, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - IR Manager Tom Vo - Chairman and CEO Jon Bates - CFO Warren Hosseinion - President Josh DeTillio - COO Conference Call Participants Bill Sutherland - The Benchmark Company Thomas McGovern - Maxim Group Gene Mannheimer - Freedom Capital Markets Joshua Cohen - Westbury Capital Operator Greetings. Welcome to Nutex Health's First Quarter 2025 Financial Results Conference Call.
- 05/14/2025
|
NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
- TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8% NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET LOSS OF $0.4 MILLION IN Q1 2024 DILUTED EPS OF $2.56 PER SHARE VERSUS $(0.08) PER SHARE IN Q1 2024 EBITDA OF $43.1 MILLION VERSUS $7.1 MILLION IN EBITDA IN Q1 2024, AN INCREASE OF 507.0% ADJUSTED EBITDA OF $72.8 MILLION VERSUS $(0.4) MILLION IN Q1 2024 NET CASH FROM OPERATING ACTIVITIES OF $51.0 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS HAVE RESULTED IN MORE FAIR AND REASONABLE PAYMENTS HOUSTON , May 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced first quarter 2025 financial results for the three months ended March 31, 2025.
- 05/13/2025
|
Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call
- HOUSTON , May 7, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2025 after the close of the stock market on Tuesday, May 13, 2025. The Company will discuss those results on a conference call on Wednesday, May 14, 2025, at 10:30 a.m.
- 05/07/2025
|
Nutex Health Achieves Blowout Earnings On Arbitration Win But There Are Too Many Unknowns
- Nutex Health Inc. reported a significant revenue increase of 270% year-over-year in Q4. The company's GAAP EPS was an impressive $11.12 for Q4 and $9.71 for the year, implying that it's trading at a bargain at first glance. The company's earnings were driven to be a substantial set of arbitration wins, with no guarantee that this will continue going forward.
- 04/02/2025
|
Nutex Health Inc. (NUTX) Q4 2024 Earnings Call Transcript
- Nutex Health Inc. (NASDAQ:NUTX ) Q4 2024 Earnings Conference Call April 1, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Carl Byrnes - Northland Capital Markets Anthony Vendetti - Maxim Group Gene Mannheimer - Freedom Capital Markets Operator Greetings, and welcome to the Nutex Health Fourth Quarter 2024 Financial Results Call. At this time all participants are in a listen-only mode.
- 04/01/2025
|
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
- FULL YEAR 2024 HIGHLIGHTS: TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8% NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF $45.8 MILLION IN 2023 DILUTED EPS OF $9.71 PER SHARE VERSUS $(10.39) PER SHARE IN 2023 EBITDA OF $98.4 MILLION VERSUS $(22.5) MILLION IN EBITDA IN 2023 ADJUSTED EBITDA OF $123.7 MILLION VERSUS $10.8 MILLION IN 2023, AN INCREASE OF 1,045.4% NET CASH FROM OPERATING ACTIVITIES OF $23.2 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS, THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS, HAS RESULTED IN MORE EQUITABLE PAYMENTS HOUSTON , March 31, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced fourth quarter 2024 and fiscal year 2024 financial results for the twelve months ended December 31, 2024. Financial highlights for the year ended December 31, 2024: Total revenue increased $232.3 million to $479.9 million for the year ended December 31, 2024 as compared to total revenue of $247.6 million for the same period in 2023, an increase of 93.8%.
- 03/31/2025
|
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
- HOUSTON , March 27, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) announced that it has rescheduled the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2024, which had previously been scheduled for March 27, 2025 and March 28, 2025, respectively. Nutex currently expects to issue its fourth quarter and full year 2024 financial results after market close on Monday, March 31, 2025, the official SEC filing deadline.
- 03/27/2025
|
Nutex Health to Present at the EDPMA Solutions Summit 2025
- HOUSTON , March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO.
- 03/20/2025
|
NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
- HOUSTON , March 17, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the fourth quarter and year ended December 31, 2024 after the close of the stock market on March 27th, 2025. The Company will discuss those results on a conference call on Friday, March 28st, 2025, at 10:30 am ET.
- 03/17/2025
|
Nutex Health Issues No Surprises Act (NSA) Arbitration Update
- HOUSTON , Feb. 5, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today provided an update regarding its strategic participation in arbitration known as the Independent Dispute Resolution ("IDR") process under the No Surprises Act ("NSA"). As previously disclosed in our September 30, 2024 Form 10-Q, on July 1, 2024 the Company contracted with a third-party vendor to assist in the recovery of certain out of network claims under the arbitration process.
- 02/05/2025
|
Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4
- HOUSTON , Jan. 21, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that its hospitals have won multiple community-driven awards and accolades in the fourth quarter of 2024. These recognitions highlight the staff's ongoing commitment to excellence in healthcare delivery.
- 01/21/2025
|
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
- NUTEX HEALTH CONTINUES TO BROADEN ITS NATIONAL PRESENCE WITH ITS FOURTH HOSPITAL OPENING IN 2024 HOUSTON , Jan. 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, announced the opening of Starkey Ranch ER & Hospital on December 30, 2024, located at 2253 Heart Pine Ave. in Odessa, Florida.
- 01/13/2025
|
NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- HOUSTON , Jan. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will be presenting at the industry's largest healthcare investment symposium— the 43rd Annual J.P. Morgan Healthcare Conference.
- 01/06/2025
|
NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
- NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024 HOUSTON , Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Milwaukee, WI 53221. The staff of medical experts at Milwaukee ER & Hospital are bringing the community 24/7/365 days of concierge-level care.
- 11/18/2024
|
Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Transcript
- Nutex Health Inc. (NASDAQ:NUTX ) Q3 2024 Earnings Conference Call November 8, 2024 10:30 AM ET Company Participants Vivian Sanders - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Tom McGovern - Maxim Operator Greetings, and welcome to the Nutex Health Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Vivian Sanders.
- 11/08/2024
|
NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS
- TOTAL REVENUE OF $222.3 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $178.0 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 122,944 FOR THE FIRST NINE MONTHS OF 2024 VS.
- 11/07/2024
|
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
- HOUSTON , Nov. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET.
- 11/05/2024
|
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
- HOUSTON , Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET.
- 11/01/2024
|
Nutex Health Inc (NUTX) Shares Up 5.48% on Oct 2
- Shares of Nutex Health Inc (NUTX, Financial) surged 5.48% in mid-day trading on Oct 2. The stock reached an intraday high of $21.86, before settling at $21.69, up from its previous close of $20.56.
- 10/02/2024
|
NUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS IN THE 3rd QUARTER OF 2024
- HOUSTON , Sept. 30, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that Nutex Health hospitals have won multiple community-driven awards and accolades in the third quarter of 2024, reflecting the staff's commitment to excellence.
- 09/30/2024
|
NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO
- Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho , Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho.
- 08/26/2024
|
Nutex Health (NUTX) Q2 2024 Earnings Call Transcript
- Nutex Health (NASDAQ:NUTX ) Q2 2024 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Jennifer Rodriguez - Investor Relations Manager Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Operator Greetings, and welcome to Nutex Health Second Quarter 2024 Financial Results Conference Call. At this time, all participants are on a listen-only mode.
- 08/10/2024
|
NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS
- TOTAL REVENUE OF $143.5 MILLION FOR THE FIRST HALF 2024 VS $115.3 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 81,276 FOR THE FIRST HALF 2024 VS VISITS OF 65,244 FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION OPERATING INCOME OF $33.3 MILLION FOR THE FIRST HALF 2024 VS $13.9 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 140% NET CASH FROM OPERATING ACTIVITIES OF $16.3 MILLION FOR THE FIRST HALF 2024 COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOW HOUSTON , Aug. 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in nine states and primary care-centric, risk-bearing physician networks, today announced second quarter 2024 financial results for the three and six months ended June 30, 2024. Financial Highlights for the Three Months Ended June 30, 2024: Total revenue of $76.1 million as compared to total revenue of $58.9 million for the three months ended June 30, 2023, an increase of 29%.
- 08/08/2024
|
NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
- HOUSTON , Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET.
- 08/05/2024
|
NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE
- HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, announced today that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market as required by the Hearing Panel's June 14, 2024 decision, as previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024.
- 07/29/2024
|
Nutex Health Hospitals Prove Patient Satisfaction with Nine Awards and Honors Earned in Q2
- HOUSTON , July 15, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced Nutex Health hospitals won nine awards in 2024's second quarter, reflecting the staff's commitment to excellence. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.
- 07/15/2024
|
NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT
- HOUSTON , June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024. The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306.
- 06/27/2024
|
NUTEX HEALTH ANNOUNCES THAT IT HAS OBTAINED APPROVAL FROM ITS SHAREHOLDERS TO EFFECT A REVERSE STOCK SPLIT
- COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 HOUSTON , June 19, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16. On June 14, 2024, the Company received notice from the Nasdaq Stock Market LLC ("Nasdaq") that a Nasdaq Hearings Panel had granted the Company an exception until July 22, 2024 to effect a reverse stock split of its common stock once approved by its Board of Directors and the Company's stockholders.
- 06/19/2024
|
NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.
- HOUSTON , May 24, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter on May21, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), the Company's Common Stock would be scheduled for delisting from The Nasdaq Capital Market and would be suspended for trading at the opening of business on May 30, 2024 unless the Company timely requests a hearing before an independent Nasdaq Hearings Panel (the "Panel") by May 28, 2024. On May 23, 2024, the Company submitted a request for a hearing to appeal the Staff's delisting determination.
- 05/24/2024
|
Nutex Health (NUTX) Q1 2024 Earnings Call Transcript
- Nutex Health (NASDAQ:NUTX ) Q1 2024 Earnings Conference Call May 10, 2024 10:30 AM ET Company Participants Jennifer Rodriguez – Investor Relations Manager Tom Vo – Chairman and Chief Executive Officer Jon Bates – Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland – The Benchmark Company Operator Greetings and welcome to the Nutex Health First Quarter 2024 Financial Results Earnings Call. At this time, all participants are in a listen-only mode.
- 05/10/2024
|
NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
- TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1% HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION IN 2023, AN INCREASE OF 119% NET CASH FROM OPERATING ACTIVITIES OF $3.1 MILLION FOR FIRST QUARTER 2024 CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATION HOUSTON , May 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced first quarter 2024 financial results for the three months ended March 31, 2024. Financial Highlights for the Three Months Ended March 31, 2024: Total revenue of $67.5 million as compared to total revenue of $56.3 million for the three months ended March 31, 2023, an increase of approximately 20%.
- 05/08/2024
|
NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
- HOUSTON , May 7, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conference call on Friday, May 10, 2024 at 10:30am ET.
- 05/07/2024
|
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING
- HOUSTON , May 6, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2024 Annual Meeting to be held on June 17, 2024 at 10:00 am Central Daylight Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2024. We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote.
- 05/06/2024
|
NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE
- HOUSTON , April 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced its second annual private leadership conference from April 30 to May 2 in Houston, Texas. The conference serves as an opportunity for Nutex Health leaders from across the country to gather, strategize and execute new and old business initiatives.
- 04/29/2024
|
NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS
- HOUSTON , April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors.
- 04/22/2024
|
Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1
- HOUSTON , April 16, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced Nutex hospitals have won seven awards and four recognitions in the first quarter of 2024, reflecting the staff's commitment to excellence. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.
- 04/16/2024
|
NUTEX HEALTH PROVIDES CORPORATE UPDATE
- COMPANY IS ADVANCING ITS ONGOING STRATEGIC PLAN DESIGNED TO SIGNIFICANTLY REDUCE COSTS, REACH POSITIVE NET INCOME AND IMPROVE CASH FLOW HOUSTON , April 12, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today provides a corporate update. As of April 11, 2024, the Company had cash and cash equivalents of approximately $25 million (unaudited).
- 04/12/2024
|
NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN
- Nutex Health expands its footprint in the northern US with its first hospital in Wisconsin. HOUSTON , April 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the opening of Green Bay ER & Hospital, located at 2465 Monroe Road in Bellevue, Wisconsin.
- 04/08/2024
|
Why Is Nutex Health (NUTX) Stock Down 13% Today?
- Nutex Health (NASDAQ: NUTX ) stock is dropping on Friday after the company announced plans for a reverse split of its shares. Nutex Health intends to enact a one-for-15 reverse stock split before markets open on April 10.
- 04/05/2024
|
NUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT
- HOUSTON , April 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-15 reverse stock split of its common stock effective with the market opening on Tuesday April 10, 2024. The reverse stock split will take legal effect at 11:59pm Eastern Time on April 9, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on April 10, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U207.
- 04/05/2024
|
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
- TOTAL REVENUE OF $247.6 MILLION FOR THE YEAR ENDED 2023 VS $219.3 MILLION IN 2022, AN INCREASE OF 13% HOSPITAL DIVISION OPERATING INCOME OF $36.3 MILLION FOR YEAR ENDED 2023 VS $15.0 MILLION IN 2022, AN INCREASE OF 142% NET CASH FROM OPERATING ACTIVITIES OF $1.3 MILLION FOR THE YEAR ENDED 2023 CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATION HOUSTON , March 28, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in eight states and primary care-centric, risk-bearing physician networks, today announced fourth quarter and fiscal year 2023 financial results for the twelve months ended December 31, 2023. Financial Highlights for the Three Months Ended December 31, 2023: Total revenue of $69.7 million as compared to total revenue of $53.7 million for the three months ended December 31, 2022, an increase of approximately 30%.
- 03/28/2024
|
3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter
- Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.
- 03/18/2024
|
NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING
- HOUSTON , March 15, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced preliminary FY 2023 headline financials and provides an update on the anticipated timing for the filing of its 10-K for the year ended December 31, 2023. The Company is finalizing its FY 2023 10-K and expects to file it with the SEC next week within the extension deadline allowed under the SEC rules.
- 03/15/2024
|
NUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENT
- Company enrolled over 2400 new Medicare Advantage patients during the annual enrollment period HOUSTON , Feb. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announces that it has more than doubled its Medicare Advantage membership during the 2023 annual enrollment period from October to December 2023. In Texas, Houston Physicians IPA ("HPIPA") enrolled over 1900 new Medicare Advantage ("MA") patients.
- 02/05/2024
|
NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN
- HOUSTON , Jan. 30, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 20 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announces full payoff of Yorkville Advisors and a new streamlined strategic plan. Nutex has paid off in full the remaining outstanding balance of $2.7 million under the Pre-Paid Advance Agreement, in lieu of future stock issuances at the discretion of Yorkville Advisors.
- 01/30/2024
|
Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants
- HOUSTON , Jan. 23, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor whereby the investor has agreed to purchase 66,666,666 shares of common stock and warrants to purchase up to an aggregate of 66,666,666 shares of common stock at a purchase price of $0.15 per share and accompanying warrant in a registered direct offering. The warrants have an exercise price of $0.15 per share, are exercisable immediately, and will expire five years following the date of issuance.
- 01/23/2024
|
NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- HOUSTON , Dec. 18, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Thomas Vo, M.D., MBA, Founder, Chairman and CEO and Warren Hosseinion, M.D.
- 12/18/2023
|
NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
- HOUSTON , Nov. 27, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospital facilities in 8 states and primary care-centric, risk-bearing physician networks, today announced that it has received a letter from Nasdaq granting it an additional 180-day extension, or until May 20, 2024, to evidence compliance with Nasdaq's $1.00 minimum bid requirement. The Company can cure this deficiency if the closing bid price of its shares of Common Stock is $1.00 per share or higher for at least 10 consecutive business days during the additional compliance period.
- 11/27/2023
|
NUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
- NET REVENUE OF $62.7 MILLION NET CASH FROM OPERATING ACTIVITIES OF $2.0 MILLION COMPANY EXPECTS TO OPEN FIVE NEW MICRO-HOPITALS IN 2024 HOUSTON , Nov. 9, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro-hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced third quarter 2023 financial results for the three months and nine months ended September 30, 2023. Financial Highlights for the Three Months and Nine Months Ended September 30, 2023: Net revenue of $62.7 million in Q3 2023 vs $28.4 million in Q3 2022.
- 11/09/2023
|
NUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE
- HOUSTON , Sept. 20, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Thomas Vo, M.D.
- 09/20/2023
|
NUTEX HEALTH ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES
- HOUSTON , Sept. 7, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Thomas Vo, M.D.
- 09/07/2023
|
Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates
- Nutex Health Inc. (NUTX) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.
- 08/09/2023
|
Why Shares of Nutex Health Jumped on Wednesday
- Nutex now operates 20 micro-hospitals across eight states. The company has posted a loss for four consecutive quarters.
- 06/21/2023
|
NUTEX HEALTH TO PRESENT AT THE STIFEL 2023 CROSS SECTOR INSIGHT CONFERENCE ON JUNE 7 IN BOSTON
- HOUSTON , June 5, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health is scheduled to present at the Stifel 2023 Cross Sector Insight Conference on June 7 in Boston, MA.
- 06/05/2023
|
Why Shares of Nutex Health Jumped on Friday
- A company director bought 50,000 shares of Nutex on Thursday. The healthcare tech provider said it plans to expand by four or five hospitals this year.
- 05/19/2023
|
NUTEX HEALTH TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
- HOUSTON , May 16, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that leadership is participating at the following investor conferences: RBC Global Healthcare Conference Date: May 16, 2023Venue: InterContinental New York Barclay Hotel Benchmark Company Healthcare House Call Conference Date: May 23, 2023 Venue: Virtual Management will be participating in one-on-one meetings at these events with investors. The Company's presentation has been filed as an 8-K with the SEC.
- 05/16/2023
|
Nutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates
- Nutex Health Inc. (NUTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.35 per share a year ago.
- 05/15/2023
|
Nutex Health: The Hype Is Over
- Nutex Health Inc. had a fluke in 2020 and 2021 with good revenue streams but has failed to capitalize on it. With lower patient visits, Nutex Health has started digging into earnings, and the company keeps on losing money quarter-over-quarter.
- 01/19/2023
|
NUTEX HEALTH TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- HOUSTON , Dec. 21, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA (CEO and Chairman), Warren Hosseinion, M.D.
- 12/21/2022
|
These Are the 10 Biggest Companies With Under 10% Institutional Ownership
- Institutional investors are companies or organizations that invest on the behalf of others.
- 12/19/2022
|
These Were the 5 Best and Worst Performing Small-Cap Stocks in November 2022
- Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns.
- 12/13/2022
|
Why Shares of Nutex Health Jumped 17.99% on Tuesday
- The technology-enabled healthcare management company is up more than 210% this past month.
- 12/06/2022
|
Why Shares of Nutex Health Jumped 28.1% Monday
- The physician network and micro-hospital company just went public in April.
- 11/28/2022
|
10 Top Penny Stocks To Buy For Uner $1 Right Now
- Penny stocks to watch under $1 right now. The post 10 Top Penny Stocks To Buy For Uner $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/21/2022
|
Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week
- Penny stocks to watch under $1 right now. The post Good Penny Stocks To Buy Now?
- 10/20/2022
|
How to Find Penny Stocks to Buy Right Now
- Use these tricks for finding penny stocks to buy this week The post How to Find Penny Stocks to Buy Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 10/18/2022
|
Best Penny Stocks To Buy Now? 3 Under $1 To Watch This Week
- What are the best penny stocks to buy this week? These 3 stocks under $1 are attracting attention right now.
- 10/17/2022
|
Why Is Nutex Health (NUTX) Stock on the Move Today?
- Source: metamorworks / Shutterstock Nutex Health (NASDAQ: NUTX ) stock is moving on Monday after the company released a corporate update to investors. The healthcare management and operations company goes over its plans for the future in this update.
- 10/10/2022
|
Why Nutex Health's Shares Fell 27.8% on Friday
- The micro hospital and primary care provider operator set a new 52-week low.
- 10/07/2022
|
4 Penny Stocks Making A Comeback In September, Time To Buy?
- Penny stocks making a comeback to watch this week. The post 4 Penny Stocks Making A Comeback In September, Time To Buy?
- 09/07/2022
|
4 Hot Penny Stocks To Buy Now According To Top Hedge Funds
- Penny stocks to buy according to top money managers. The post 4 Hot Penny Stocks To Buy Now According To Top Hedge Funds appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 09/06/2022
|
Give Nutex Health More Time Before Buying the Stock
- NUTX stock exploded in both price and popularity following a recent merger. However, investors should take a wait and see approach with the company.
- 05/24/2022
|
Contrarians May Want to Take a Look at Nutex Health Stock
- Falling fast out of favor, NUTX stock may be a great opportunity for risk-tolerant investors willing to go against the grain. The post Contrarians May Want to Take a Look at Nutex Health Stock appeared first on InvestorPlace.
- 05/18/2022
|
Post-Merger, Nutex Health Stock Is Notably Cheap
- To get direct exposure to an up-and-coming business in the integrated care delivery niche, consider owning NUTX stock at a nice price. The post Post-Merger, Nutex Health Stock Is Notably Cheap appeared first on InvestorPlace.
- 05/13/2022
|
